IDEVvsXPH
iShares Core MSCI International Developed Markets ETF against SPDR S&P Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IDEV | XPH | |
|---|---|---|
| Expense ratio | 0.040% | 0.35% |
| Assets | $34B | $528M |
| Net flow, 1 month | +$587M | +$50M |
| Net flow, 1 year | +$8B | +$263M |
| Return, YTD | +7.2% | +16.7% |
| Return, 1 year | — | — |
| Avg daily volume | 2.2M | 208K |
| Holdings | 2310 | 61 |
| Listed | Mar 21, 2017 | Jun 19, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS